ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	-	-	-	-	0	0
Revenue Growth (YoY)	-	-	-	-	30.20%	153.05%
Cost of Revenue	6.5	7.88	16.09	4.63	3.18	4.74
Gross Profit	-6.5	-7.88	-16.09	-4.63	-3.18	-4.73
Selling, General & Admin	5.67	5.58	5.99	3.66	2.48	2.66
Operating Expenses	5.67	5.58	5.99	3.66	2.48	2.66
Operating Income	-12.17	-13.46	-22.08	-8.29	-5.66	-7.4
Interest Expense	-0.28	-0.2	-0.28	-0.42	-	-
Interest & Investment Income	-	-	-	-	0	-
Other Non Operating Income (Expenses)	1.36	1.25	4.29	-1.08	-	-
EBT Excluding Unusual Items	-11.09	-12.41	-18.07	-9.79	-5.66	-7.4
Other Unusual Items	-0.8	-0.8	0.01	-	-	-
Pretax Income	-11.89	-13.21	-18.06	-9.79	-5.66	-7.4
Net Income	-11.89	-13.21	-18.06	-9.79	-5.66	-7.4
Net Income to Common	-11.89	-13.21	-18.06	-9.79	-5.66	-7.4
Shares Outstanding (Basic)	15	12	8	6	5	4
Shares Outstanding (Diluted)	15	12	8	6	5	4
Shares Change (YoY)	91.52%	63.85%	29.68%	21.55%	9.93%	8.61%
EPS (Basic)	-0.79	-1.07	-2.41	-1.69	-1.19	-1.71
EPS (Diluted)	-0.79	-1.07	-2.41	-1.69	-1.19	-1.71
Free Cash Flow	-18.57	-10.84	-17.04	-9.31	-4.46	-6.09
Free Cash Flow Per Share	-1.24	-0.88	-2.27	-1.61	-0.94	-1.41
Operating Margin	-	-	-	-	-361828.37%	-615329.37%
Free Cash Flow Margin	-	-	-	-	-285199.36%	-506627.70%
EBITDA	-12.14	-13.44	-22.07	-8.25	-5.65	-7.39
D&A For EBITDA	0.02	0.02	0.01	0.05	0.02	0.01
EBIT	-12.17	-13.46	-22.08	-8.29	-5.66	-7.4
Revenue as Reported	-	-	-	-	0	-

Source: S&P Capital IQ. Standard template.